Avro Life Science

Avro Life Science is a clinical-stage biotech focused on enabling topical skin delivery of novel drug classes through its transdermal platform technologies. They describe a pipeline and platform for passive delivery into the skin for dermatology applications.

The company promotes a topical/skin-delivery platform (TransdermIL Platform) and related product candidates (AVR 235, AVR 335) intended to enable passive delivery of drugs into the skin, supporting dermatology indications. The site references a pipeline and platform technologies named TopiqIL Platform and TransdermIL Platform, along with clinical-stage programs, suggesting combination of platform technology with specific product candidates targeted at skin-based therapeutic delivery.

Who it’s for: Pharmaceutical/biotech companies focusing on dermatology and transdermal drug delivery, contract research or development partners seeking novel topical delivery platforms.

clinical-stage; mentions of a pipeline and platform; corporate website indicates alignment with affiliations